Accessibility navigation


Active control comparisons: the ideal trial design

Brodie, M.J. and Whitehead, J. (2006) Active control comparisons: the ideal trial design. Epilepsy Research, 68 (1). 69-73 . ISSN 0920-1211

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1016/j.eplepsyres.2005.09.025

Abstract/Summary

This report describes the concept for a clinical trial that uses carbamazepine as the gold-standard active control for a study of newly diagnosed patients. The authors describe an endpoint including efficacy and tolerability, and a stopping rule that uses a series of interim analyses in order to reach a conclusion as efficiently as possible without sacrificing reliability.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Science > School of Mathematical, Physical and Computational Sciences > Department of Mathematics and Statistics > Applied Statistics
ID Code:9479

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation